Skip to content

Washington · Nonprofit

SEATTLE BIOMEDICAL RESEARCH INSTITUTE

SEATTLE BIOMEDICAL RESEARCH INSTITUTE (Washington) receives grants from 20 organizations whose IRS filings report $10,632,906 to it, the largest being INTERNATIONAL AIDS VACCINE INITIATIVE INC ($3,480,171). 11 of them have funded it in more than one year.

Revenue FY2019
$9.0M
Funders on record
20
Grants received
$11M
Net assets
$0
11/20 repeat funderspeak grant-dependency 14%
01What it does

What Seattle Biomedical Research Institute does

Mission

We conduct fundamental infectious disease research to generate critical new knowledge about pathogens and their interactions with see schedule o for continuationhumans to enable the discovery and development of novel interventions, rational vaccines, therapeutic targets, drugs and diagnostics. These diseases include, but are not limited to, tuberculosis, malaria, and hiv.we are also engaged in training the next generation of scientists who will perform scientific research and add clinical capacity throughout the world.

As stated on its FY2019 Form 990.

Program

We conduct fundamental infectious disease research to generate critical new knowledge about pathogens and their interactions with humans to enable the discovery and development of novel interventions, rational vaccines, therapeutic targets, drugs and diagnostics. These diseases include, but are not limited to, tuberculosis, malaria, and hiv. We are also engaged in training the next generation of scientists who will perform scientific research and add clinical capacity throughout the world.see schedule o for continuationaccomplishments include: -discovery of rna editing, which provides a potential basis for drug treatments for three major parasitic diseases.-identification of two hiv1 envelope antigens that elicited broadly neutralizing antibodies against hiv when introduced as a trial vaccine in primates.-genetically engineered the malaria parasite p. Falciparum by the precise removal of specific genes, creating a strain that infects humans and is well tolerated but cannot cause malaria, thus making it a novel new vaccine candidate.

The first program described on its most recent Form 990, which lists programs largest first by expense.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended.

100 = 20172017 Revenue 100 ($33M) Expenses 100 ($37M) Net assets 100 ($30M)2018 Revenue 91 ($30M) Expenses 93 ($34M) Net assets 87 ($26M)2019 Revenue 27 ($9.0M) Expenses 94 ($35M) Net assets 0 ($0)
201720182019
Revenue (27)Expenses (94)Net assets (0)

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2018 to 2019, from $34M to $0 (−100%).

$37M
$34M
$0
201720182019
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2017 76% · 2018 84% · 2019 83%. Grants only. Government contracts and fees sit inside program revenue.

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 3 reported years ran a deficit.

−$3.8M
’17
−$3.9M
’18
−$26M
’19
1.4
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

201720182019
Listed312927
Joined·+1+2
No longer listed·34
03Who funds it

Who funds it, year by year

2017 → 2023: the base narrowed from 15 funders to 1 funder, grant income fell $4.4M → $270k.

7 of 20 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 9% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of SEATTLE BIOMEDICAL RESEARCH INSTITUTE’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

SEATTLE BIOMEDICAL RESEARCH INSTITUTE leans on a few funders — its largest provides 33% of grant income and the top three 67%; half comes from just 2 funders.

the vertical line marks half of all grant income — 2 funders to its left

87% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund SEATTLE BIOMEDICAL RESEARCH INSTITUTE.

33%
largest funder
67%
top three
~5
effective funders

Largest funder’s share by year: 2017 47% · 2018 21% · 2019 50% · 2020 92% · 2021 100% · 2022 100% · 2023 100% — growing more concentrated.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

10% of SEATTLE BIOMEDICAL RESEARCH INSTITUTE's funders are still giving 3 years after their first grant; 55% give in more than one year at all.

first grant+1y+2y+3y+4y+5y+6y

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

SEATTLE BIOMEDICAL RESEARCH INSTITUTE draws 57% of its grant income from funders outside Washington, across 8 states in all.

WA
NY
MA
NV
CA
MO
TN
TX

In-state vs out-of-state, by year

’17
’18
’19
’20
’21
’22
’23
Washington out of state home

Funder states come from each funder’s own filing. $935k arriving through sponsors registered in 6 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Government funding SEATTLE BIOMEDICAL RESEARCH INSTITUTE receives

Grants and contracts to this organization from federal (USASpending) and state checkbooks, reconciled to its EIN. $45.0M on record.

Federal$45.0M
grants $35.9Mcontracts $9.1M
17
18
19
20
Top agencies
  • Department of Health and Human Services$44.3M
  • Department of Defense$682k

Federal grants vs contracts are distinguished; state line items keep their reported category. Matched by name + geography (the BMF), so coverage is partial and precision-first.

Organizations like SEATTLE BIOMEDICAL RESEARCH INSTITUTE

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Washington

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

90% of spending goes to programs.

Program 90%Management 10%Fundraising 0%

Governance

3
board members
100%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention✓Board reviewed the 990–Audited financials

Footprint & structure

Files a return copy in 1 state

WA

Screen this organization

A dated, signed PDF of the compliance screen for SEATTLE BIOMEDICAL RESEARCH INSTITUTE: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds SEATTLE BIOMEDICAL RESEARCH INSTITUTE?
SEATTLE BIOMEDICAL RESEARCH INSTITUTE (Washington) receives grants from 20 organizations whose IRS filings report $10,632,906 to it, the largest being INTERNATIONAL AIDS VACCINE INITIATIVE INC ($3,480,171). 11 of them have funded it in more than one year.
How many funders does SEATTLE BIOMEDICAL RESEARCH INSTITUTE have?
IRS filings report 20 organizations giving $10,632,906 in grants to SEATTLE BIOMEDICAL RESEARCH INSTITUTE, 11 of which have funded it in more than one year.
Who is the largest funder of SEATTLE BIOMEDICAL RESEARCH INSTITUTE?
INTERNATIONAL AIDS VACCINE INITIATIVE INC is the largest funder on record, with $3,480,171 in grants. The full list of funders is on this page.
How can an organization like SEATTLE BIOMEDICAL RESEARCH INSTITUTE find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Washington. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2019 (financials across 2017–2019), and the filings of 20 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing